Research Article

Highlights of Thirty-Year Experience of C O 2 Laser Use at the Florence (Italy) Department of Dermatology

Table 1

Treated lesions.

Benign epidermal tumours
 Seborrheic keratoses
 Follicular inverse keratoses
 Epidermal and sebaceous nevi
35.720
75
5706
Frequency: 10 HZ
Power: 0.5–3 W

Benign pilar and sebaceous tumours
 Facial Milia
 Trichoepitheliomas
 Sebaceous adenoma
 Small sebaceous cysts
12.230
2.570
8.040
425
Frequency: 10 HZ
Power: 0.5–1 W

Benign tumours of eccrine glands
Syringomas
1235Frequency: 10 HZ
Power: 0.5–1 W

Malign epidermal tumours
 Basal Cell carcinoma (Bcc)
  Superficial (also extensive)
  Nodular (<1 cm diameter)
2505Frequency: 10 HZ
Power: 0.5–5 W

Viral lesions
 Warts
 Acuminate condylomas
 Squamous papillomas
 Oral cavity
12.235
8.503
58
Frequency: 10 HZ
Power: 0.5–3 W
For Plantar Warts: Continuous Mode (Power 10–15 W)

Dermal hypertrophy
 Pendulous fibromas
 Skin neurofibromas
45.023
150
Frequency: 10 HZ
Power: 0.5–1 W

Scars
 Acne, surgical, traumatic, post-chickenpox
7.502Frequency: 10 HZ
Power: 0.5–1 W

Fatty accumulation
 Xanthelasmas
7.234Frequency: 10 HZ
Power: 0.5–1 W

Facial dermatosis
 Rhynophymas (glandular type)
 Otophyma
506
35
Frequency: 50–100 W
Power: 6-7 W (Superpulse or Continuous Mode)

Precancerous
 Actinic keratoses
 Actinic cheilitis
 Leukoplakia
25.213
807
503
Frequency: 10 HZ
Power: 0.5−3 W

Others
 Favre-Racouchot’s disease
 Pringle-Bourneville’s disease
 Chondrodermatites nodularis helicis
124
304
432
Frequency: 10 HZ
Power: 0.5–1 W